Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study

被引:86
作者
Terada, Tatsuhiro [1 ]
Yokokura, Masamichi [2 ]
Yoshikawa, Etsuji [3 ]
Futatsubashi, Masami [3 ]
Kono, Satoshi [4 ]
Konishi, Takashi [4 ]
Miyajima, Hiroaki [4 ]
Hashizume, Takanori [5 ]
Ouchi, Yasuomi [1 ]
机构
[1] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Dept Biofunct Imaging, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan
[2] Hamamatsu Univ Sch Med, Dept Psychiat, Hamamatsu, Shizuoka, Japan
[3] Hamamatsu Photon KK, Cent Res Lab, Hamamatsu, Shizuoka, Japan
[4] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka, Japan
[5] Osaka Ohtani Univ, Tondabayashi, Japan
关键词
Parkinson's disease (PD); Microglia; C-11]DPA713; Positron emission tomography (PET); LEWY BODIES; ZONISAMIDE; PET; ALZHEIMERS; NEUROINFLAMMATION; PATHOLOGY; DEMENTIA; NEURONS; MODEL;
D O I
10.1007/s12149-016-1099-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The neuroinflammatory glial response contributes to the degenerative process in Parkinson's disease (PD). However, the pattern of microglial progression remains unclear. We evaluated microglial activation in early stage PD patients by quantifying changes in neuroinflammation using PET with [C-11]DPA713, a selective PET tracer for microglial activation. Eleven PD patients (Hoehn and Yahr stages 1-2) without dementia underwent the [C-11]DPA713 PET scan two times with 1 year apart. The binding potential (BPND) was estimated with the simplified reference tissue model. Voxelwise and regions of interest analyses were used to compare the regional BPND among groups. Significant increase in [C-11]DPA713 BPND was found extrastriatally in the occipital, temporal and parietal cortex in PD patients, and the degree of BPND became much higher over the brain regions predominantly in the temporal and occipital cortex 1 year later. The current results indicated that an extrastriatal spreading of microglial activation reflects one of PD pathophysiology occurring at an early stage.
引用
收藏
页码:579 / 587
页数:9
相关论文
共 29 条
[1]   Neuroprotective Effects of Zonisamide Target Astrocyte [J].
Asanuma, Masato ;
Miyazaki, Ikuko ;
Diaz-Corrales, Francisco J. ;
Kimoto, Naotaka ;
Kikkawa, Yuri ;
Takeshima, Mika ;
Miyoshi, Ko ;
Murata, Miho .
ANNALS OF NEUROLOGY, 2010, 67 (02) :239-249
[2]   Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].
Banati, RB ;
Daniel, SE ;
Blunt, SB .
MOVEMENT DISORDERS, 1998, 13 (02) :221-227
[3]   [11C]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease? [J].
Bartels, A. L. ;
Willemsen, A. T. M. ;
Doorduin, J. ;
de Vries, E. F. J. ;
Dierckx, R. A. ;
Leenders, K. L. .
PARKINSONISM & RELATED DISORDERS, 2010, 16 (01) :57-59
[4]   Zonisamide-induced long-lasting recovery of dopaminergic neurons from MPTP-toxicity [J].
Choudhury, Mohammed Emamussalehin ;
Moritoyo, Takashi ;
Kubo, Madoka ;
Kyaw, Win Thiri ;
Yabe, Hayato ;
Nishikawa, Noriko ;
Nagai, Masahiro ;
Matsuda, Seiji ;
Nomoto, Masahiro .
BRAIN RESEARCH, 2011, 1384 :170-178
[5]   Detection of Microglial Activation in an Acute Model of Neuroinflammation Using PET and Radiotracers 11C-(R)-PK11195 and 18F-GE-180 [J].
Dickens, Alex M. ;
Vainio, Susanne ;
Marjamaki, Paivi ;
Johansson, Jarkko ;
Lehtiniemi, Paula ;
Rokka, Johanna ;
Rinne, Juha ;
Solin, Olof ;
Haaparanta-Solin, Merja ;
Jones, Paul A. ;
Trigg, William ;
Anthony, Daniel C. ;
Airas, Laura .
JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (03) :466-472
[6]   Microglia, Amyloid, and Glucose Metabolism in Parkinson's Disease with and without Dementia [J].
Edison, Paul ;
Ahmed, Imtiaz ;
Fan, Zhen ;
Hinz, Rainer ;
Gelosa, Giorgio ;
Chaudhuri, K. Ray ;
Walker, Zuzana ;
Turkheimer, Federico E. ;
Brooks, David J. .
NEUROPSYCHOPHARMACOLOGY, 2013, 38 (06) :938-949
[7]   In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease [J].
Gerhard, A ;
Pavese, N ;
Hotton, G ;
Turkheimer, F ;
Es, M ;
Hammers, A ;
Eggert, K ;
Oertel, W ;
Banati, RB ;
Brooks, DJ .
NEUROBIOLOGY OF DISEASE, 2006, 21 (02) :404-412
[8]   Zonisamide: A review of the clinical and experimental evidence for its use in Parkinson's disease [J].
Grover, Neeta D. ;
Limaye, Ramachandra P. ;
Gokhale, Dilip V. ;
Patil, Tatyasaheb R. .
INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 (06) :547-555
[9]  
Hagell Peter, 2009, Ther Adv Neurol Disord, V2, P205, DOI 10.1177/1756285609103726
[10]   ZUNG SELF-RATING DEPRESSION SCALE SCORES OF PSYCHIATRIC OUTPATIENTS BY AGE AND SEX [J].
HOLMES, CB ;
WURTZ, PJ ;
FOUTY, HE ;
BURDICK, BM .
PSYCHOLOGICAL REPORTS, 1988, 62 (01) :259-262